Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Choy

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
RSC Medicinal Chemistry|January 22, 2021
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against <i>Trypanosoma brucei</i>Zhongsheng Zhang, Ximena Barros-Álvarez, J Robert Gillespie, et al.
Elife|May 24, 2024
Secreted dengue virus NS1 from infection is predominantly dimeric and in complex with high-density lipoproteinBing Liang Alvin Chew, A N Qi Ngoh, Wint Wint Phoo, et al.
Structure (London, England : 1993)|January 1, 2026
Cross-linking mass spectrometry and structural modeling identifies compact conformation of DENV NS2B cofactor region bound to NS3Zheng Ser, Wint Wint Phoo, Teo Chwee Fang Fyn, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
Frontiers in Drug Delivery|August 21, 2025
Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccineWilliam R Lykins, Jeroen Pollet, Jessica A White, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 10, 2024
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023Marco Cavaleri, David Kaslow, Eric Boateng, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
Vaccine|November 29, 2023
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentationsSoumalya Banerjee, Eileen M Barry, Shahida Baqar, et al.
Frontiers in Immunology|December 31, 2024
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilizationWilliam R Lykins, Jeroen Pollet, Jessica A White, et al.
Plos Neglected Tropical Diseases|August 11, 2016
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsCynthia Sung, Yuan Wei, Satoru Watanabe, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
RSC Medicinal Chemistry|January 22, 2021
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against <i>Trypanosoma brucei</i>Zhongsheng Zhang, Ximena Barros-Álvarez, J Robert Gillespie, et al.
Elife|May 24, 2024
Secreted dengue virus NS1 from infection is predominantly dimeric and in complex with high-density lipoproteinBing Liang Alvin Chew, A N Qi Ngoh, Wint Wint Phoo, et al.
Structure (London, England : 1993)|January 1, 2026
Cross-linking mass spectrometry and structural modeling identifies compact conformation of DENV NS2B cofactor region bound to NS3Zheng Ser, Wint Wint Phoo, Teo Chwee Fang Fyn, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
Frontiers in Drug Delivery|August 21, 2025
Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccineWilliam R Lykins, Jeroen Pollet, Jessica A White, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 10, 2024
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023Marco Cavaleri, David Kaslow, Eric Boateng, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
Vaccine|November 29, 2023
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of abstract-based presentationsSoumalya Banerjee, Eileen M Barry, Shahida Baqar, et al.
Frontiers in Immunology|December 31, 2024
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilizationWilliam R Lykins, Jeroen Pollet, Jessica A White, et al.
Plos Neglected Tropical Diseases|August 11, 2016
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsCynthia Sung, Yuan Wei, Satoru Watanabe, et al.
Pageof 27